Full text loading...
-
Tuberculosis: Current Progress in Drug Targets, Potential Drugs and Therapeutic Impact
- Source: Current Respiratory Medicine Reviews, Volume 18, Issue 3, Aug 2022, p. 165 - 170
-
- 01 Aug 2022
Abstract
The World Health Organization (WHO) considers tuberculosis to be the most dangerous chronic communicable disease in the world, infecting two billion people or one-third of the world’s population. Tuberculosis (TB) caused by Mycobacterium tuberculosis remains a leading cause of mortality worldwide into the 21st century. Tuberculosis is second only to AIDS among other infectious diseases causing deaths worldwide. The emergence of AIDS, multidrug-resistant TB (MDRTB), extensively drug-resistant tuberculosis (XDR-TB), the decline of socioeconomic standards, and a reduced emphasis on tuberculosis control programmers contribute to the disease’s resurgence in industrialized countries.
© Bentham Science Publishers